AIM: To characterize small bowel (SB) tumors detected by capsule endoscopy (CE), and identify missed tumors. METHODS: The study included 145 consecutive patients in whom 150 CEs were performed. Following CE, the medical records of the study population were reviewed. Results of double- or single-balloon enteroscopy performed after CE and the results of surgery in all patients operated on were retrieved. The patients were contacted through telephone interviews or postal mail. In addition, the national cancer registry and the polish clinical gastrointestinal stromal tumor (GIST) Registry were searched to identify missed neoplasms. RESULTS: Indications for CE included overt and occult obscure gastrointestinal bleeding (n = 81, 53.7%), anemia (n = 19, 12.7%), malabsorption (n = 18, 12%), abnormal CB follow through (n = 9, 6%), abdominal pain (n = 7, 5%), celiac disease (n = 5, 3%), neuroendocrine tumor (n = 3, 2%), Crohn's disease (n = 2, < 2%), Peutz-Jeghers syndrome (n = 2, < 2%), other polyposes (n = 2, < 2%), and diarrhea (n = 2, < 2%). The capsule reached the colon in 115 (76.6%) examinations. In 150 investigations, CE identified 15 SB tumors (10%), 14 of which were operated on or treated endoscopically. Malignancies included metastatic melanoma (n = 1), adenocarcinoma (n = 2), and GIST (n = 3). Benign neoplasms included dysplastic Peutz-Jeghers polyps (n = 4). Non-neoplastic masses included venous malformation (n = 1), inflammatory tumors (n = 2), and a mass of unknown histology (n = 1). During the follow-up period, three additional SB tumors were found (2 GISTs and one mesenteric tumor of undefined nature). The National Cancer Registry and Polish Clinical GIST Registry revealed no additional SB neoplasms in the post-examination period (follow-up: range 4.2-102.5 mo, median 39 mo). The sensitivity of CE for tumor detection was 83.3%, and the negative predictive value was 97.6%. The specificity and positive predictive value were both 100%. CONCLUSION: Neoplasms may be missed by CE, especially in the proximal SB. In overt obscure gastrointestinal bleeding, complementary endoscopic and/or radiologic diagnostic tests are indicated.
AIM: To characterize small bowel (SB) tumors detected by capsule endoscopy (CE), and identify missed tumors. METHODS: The study included 145 consecutive patients in whom 150 CEs were performed. Following CE, the medical records of the study population were reviewed. Results of double- or single-balloon enteroscopy performed after CE and the results of surgery in all patients operated on were retrieved. The patients were contacted through telephone interviews or postal mail. In addition, the national cancer registry and the polish clinical gastrointestinal stromal tumor (GIST) Registry were searched to identify missed neoplasms. RESULTS: Indications for CE included overt and occult obscure gastrointestinal bleeding (n = 81, 53.7%), anemia (n = 19, 12.7%), malabsorption (n = 18, 12%), abnormal CB follow through (n = 9, 6%), abdominal pain (n = 7, 5%), celiac disease (n = 5, 3%), neuroendocrine tumor (n = 3, 2%), Crohn's disease (n = 2, < 2%), Peutz-Jeghers syndrome (n = 2, < 2%), other polyposes (n = 2, < 2%), and diarrhea (n = 2, < 2%). The capsule reached the colon in 115 (76.6%) examinations. In 150 investigations, CE identified 15 SB tumors (10%), 14 of which were operated on or treated endoscopically. Malignancies included metastatic melanoma (n = 1), adenocarcinoma (n = 2), and GIST (n = 3). Benign neoplasms included dysplastic Peutz-Jeghers polyps (n = 4). Non-neoplastic masses included venous malformation (n = 1), inflammatory tumors (n = 2), and a mass of unknown histology (n = 1). During the follow-up period, three additional SB tumors were found (2 GISTs and one mesenteric tumor of undefined nature). The National Cancer Registry and Polish Clinical GIST Registry revealed no additional SB neoplasms in the post-examination period (follow-up: range 4.2-102.5 mo, median 39 mo). The sensitivity of CE for tumor detection was 83.3%, and the negative predictive value was 97.6%. The specificity and positive predictive value were both 100%. CONCLUSION:Neoplasms may be missed by CE, especially in the proximal SB. In overt obscure gastrointestinal bleeding, complementary endoscopic and/or radiologic diagnostic tests are indicated.
Entities:
Keywords:
Capsule endoscopy; Gastrointestinal bleeding; Gastrointestinal stromal tumor; Small bowel tumor; Tumor miss rate
Authors: Adam A Bailey; Henry S Debinski; Mark N Appleyard; Matthew L Remedios; Judy E Hooper; Alissa J Walsh; Warwick S Selby Journal: Am J Gastroenterol Date: 2006-10 Impact factor: 10.864
Authors: Shabana F Pasha; Jonathan A Leighton; Ananya Das; M Edwyn Harrison; G Anton Decker; David E Fleischer; Virender K Sharma Journal: Clin Gastroenterol Hepatol Date: 2008-03-20 Impact factor: 11.382
Authors: Andrew Ross; Shahab Mehdizadeh; Jeffrey Tokar; Jonathan A Leighton; Ahmad Kamal; Ann Chen; Drew Schembre; Gary Chen; Kenneth Binmoeller; Richard Kozarek; Irving Waxman; Charles Dye; Lauren Gerson; M Edwyn Harrison; Oleh Haluszka; Simon Lo; Carol Semrad Journal: Dig Dis Sci Date: 2008-02-13 Impact factor: 3.199
Authors: E Rondonotti; M Pennazio; E Toth; P Menchen; M E Riccioni; G D De Palma; F Scotto; D De Looze; T Pachofsky; I Tacheci; T Havelund; G Couto; A Trifan; A Kofokotsios; R Cannizzaro; E Perez-Quadrado; R de Franchis Journal: Endoscopy Date: 2008-05-08 Impact factor: 10.093
Authors: Aymer Postgate; Edward Despott; David Burling; Arun Gupta; Robin Phillips; James O'Beirne; David Patch; Chris Fraser Journal: Gastrointest Endosc Date: 2008-12 Impact factor: 9.427
Authors: E Estévez; B González-Conde; J L Vázquez-Iglesias; P A Alonso; M de los Angeles Vázquez-Millán; R Pardeiro Journal: Surg Endosc Date: 2007-03-14 Impact factor: 3.453
Authors: Cristiano Spada; Deirdre McNamara; Edward J Despott; Samuel Adler; Brooks D Cash; Ignacio Fernández-Urién; Hrvoje Ivekovic; Martin Keuchel; Mark McAlindon; Jean-Christophe Saurin; Simon Panter; Cristina Bellisario; Silvia Minozzi; Carlo Senore; Cathy Bennett; Michael Bretthauer; Mario Dinis-Ribeiro; Dirk Domagk; Cesare Hassan; Michal F Kaminski; Colin J Rees; Roland Valori; Raf Bisschops; Matthew D Rutter Journal: United European Gastroenterol J Date: 2019-05-15 Impact factor: 4.623
Authors: Carlo Calabrese; Paolo Gionchetti; Andrea Calafiore; Nico Pagano; Massimo Campieri; Fernando Rizzello Journal: Intern Emerg Med Date: 2015-09-09 Impact factor: 3.397